BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36533702)

  • 21. Quantitative assessment of DNA methylation for the detection of cervical and endometrial adenocarcinomas in liquid-based cytology specimens.
    Kim GE; Kweon SS; Lee JS; Lee JH; Nam JH; Choi C
    Anal Quant Cytopathol Histpathol; 2012 Aug; 34(4):195-203. PubMed ID: 23016466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging.
    Green RW; Epstein E
    Ultrasound Obstet Gynecol; 2020 Jul; 56(1):96-105. PubMed ID: 31647145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Epigenomics Analysis Reveals a DNA Methylation Panel for Endometrial Cancer Detection Using Cervical Scrapings.
    Huang RL; Su PH; Liao YP; Wu TI; Hsu YT; Lin WY; Wang HC; Weng YC; Ou YC; Huang TH; Lai HC
    Clin Cancer Res; 2017 Jan; 23(1):263-272. PubMed ID: 27507616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of endometrial cancer via molecular analysis of DNA collected with vaginal tampons.
    Bakkum-Gamez JN; Wentzensen N; Maurer MJ; Hawthorne KM; Voss JS; Kroneman TN; Famuyide AO; Clayton AC; Halling KC; Kerr SE; Cliby WA; Dowdy SC; Kipp BR; Mariani A; Oberg AL; Podratz KC; Shridhar V; Sherman ME
    Gynecol Oncol; 2015 Apr; 137(1):14-22. PubMed ID: 25677060
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
    van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
    Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Validation of a Serum Metabolomic Signature for Endometrial Cancer Screening in Postmenopausal Women.
    Troisi J; Raffone A; Travaglino A; Belli G; Belli C; Anand S; Giugliano L; Cavallo P; Scala G; Symes S; Richards S; Adair D; Fasano A; Bottigliero V; Guida M
    JAMA Netw Open; 2020 Sep; 3(9):e2018327. PubMed ID: 32986110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of liquid-based genetic diagnosis of endometrial cancer.
    Matsuura M; Yamaguchi K; Tamate M; Satohisa S; Teramoto M; Iwasaki M; Sugita S; Hasegawa T; Koubo R; Takane K; Ikenoue T; Furukawa Y; Saito T
    Cancer Sci; 2018 Dec; 109(12):4025-4032. PubMed ID: 30289582
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
    Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of ultrasound strategies to assess tumor extension and to predict high-risk endometrial cancer in women from the prospective IETA (International Endometrial Tumor Analysis)-4 cohort.
    Verbakel JY; Mascilini F; Wynants L; Fischerova D; Testa AC; Franchi D; Frühauf F; Cibula D; Lindqvist PG; Fruscio R; Haak LA; Opolskiene G; Alcazar JL; Mais V; Carlson JW; Sladkevicius P; Timmerman D; Valentin L; Bosch TVD; Epstein E
    Ultrasound Obstet Gynecol; 2020 Jan; 55(1):115-124. PubMed ID: 31225683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.
    Multinu F; Chen J; Madison JD; Torres M; Casarin J; Visscher D; Shridhar V; Bakkum-Gamez J; Sherman M; Wentzensen N; Mariani A; Walther-Antonio M
    Gynecol Oncol; 2020 Mar; 156(3):682-688. PubMed ID: 31902687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma.
    Ayhan A; Bozdag G; Taskiran C; Gultekin M; Yuce K; Kucukali T
    Gynecol Oncol; 2006 Dec; 103(3):902-5. PubMed ID: 16828847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of prediction models for endometrial cancer in postmenopausal bleeding.
    Wong AS; Cheung CW; Fung LW; Lao TT; Mol BW; Sahota DS
    Eur J Obstet Gynecol Reprod Biol; 2016 Aug; 203():220-4. PubMed ID: 27344124
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial.
    Rijkaart DC; Berkhof J; Rozendaal L; van Kemenade FJ; Bulkmans NW; Heideman DA; Kenter GG; Cuzick J; Snijders PJ; Meijer CJ
    Lancet Oncol; 2012 Jan; 13(1):78-88. PubMed ID: 22177579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study of cervical cancer screening algorithms].
    Zhao FH; Zhang WH; Pan QJ; Zhang X; Chen W; Liu B; Ma JF; Hu SY; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2010 Jun; 32(6):420-4. PubMed ID: 20819481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and external validation of new ultrasound-based mathematical models for preoperative prediction of high-risk endometrial cancer.
    Van Holsbeke C; Ameye L; Testa AC; Mascilini F; Lindqvist P; Fischerova D; Frühauf F; Fransis S; de Jonge E; Timmerman D; Epstein E
    Ultrasound Obstet Gynecol; 2014 May; 43(5):586-95. PubMed ID: 24123609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.